Gelesis Holdings Inc., (GLS) News
Filter GLS News Items
GLS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GLS News Highlights
- For GLS, its 30 day story count is now at 2.
- Over the past 6 days, the trend for GLS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about GLS are BMI, EAT and SGHT.
Latest GLS News From Around the Web
Below are the latest news stories about GELESIS HOLDINGS INC that investors may wish to consider to help them evaluate GLS as an investment opportunity.
Sight Sciences Appoints Ali Bauerlein as Chief Financial OfficerAli Bauerlein Ali Bauerlein has been appointed Sight Sciences’ Chief Financial Officer and Treasurer, effective April 3, 2023 MENLO PARK, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announces the appointment of Alison “Ali” Bauerlein as its Chief Financial Officer and Treasurer, effective April |
Gelesis Reports Fourth Quarter and Full Year 2022 ResultsBOSTON, March 28, 2023--Gelesis Holdings, Inc. (NYSE: GLS) ("Gelesis" or the "Company"), the maker of Plenity for weight management, today reported financial results for the year ended December 31, 2022. Plenity is a novel orally administered, FDA-cleared weight management therapy that helps people feel satisfied with smaller portions, so they can eat less and lose weight, while still enjoying the foods they love. Plenity is the only FDA-cleared aid for weight management for people with a BMI as |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWe're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning! |
Gelesis to Participate in the 25th Annual ICR ConferenceBOSTON, January 05, 2023--Gelesis (NYSE: GLS), the maker of Plenity for weight management, today announced that the Company will participate in the 25th Annual ICR Conference in Orlando, Florida on Monday, January 9, 2023. |
Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth ConferenceBOSTON, November 21, 2022--Gelesis Holdings, Inc. (NYSE: GLS) ("Gelesis" or the "Company"), the maker of Plenity for weight management, today announced that its Chief Operating & Commercial Officer, David Pass, Pharm.D., will be featured in a panel discussion at Wolfe Research’s virtual Consumer Growth Conference. |
Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-ComplianceBOSTON, November 18, 2022--Gelesis Holdings Inc. (NYSE: GLS) ("Gelesis" or the "Company") today noted that on November 16, 2022, the Company received a notification letter (the "Notice") from the New York Stock Exchange (the "NYSE") advising that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual because its total market capitalization was less than $50 million over a 30 trading-day period and its stockholders’ equity was l |
Gelesis Reports Third Quarter 2022 ResultsBOSTON, November 14, 2022--Gelesis Holdings, Inc. (NYSE: GLS) ("Gelesis" or the "Company"), the maker of Plenity for weight management, today reported financial results for the third quarter of 2022. Plenity is a novel orally administered, FDA-cleared weight management therapy that helps people feel satisfied with smaller portions, so they can eat less and lose weight, while still enjoying the foods they love. Plenity is the only FDA-cleared aid for weight management for people with a BMI as low |
Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022BOSTON, November 07, 2022--Gelesis Holdings, Inc. (NYSE:GLS) ("Gelesis" or the "Company"), the maker of Plenity® for weight management, today announced that the Company will report financial results for the third quarter ended September 30, 2022, on November 14, 2022 prior to the market open. Gelesis management will host a live conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. |
Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-ComplianceBOSTON, November 04, 2022--Gelesis Holdings Inc. (NYSE: GLS) ("Gelesis" or the "Company") today noted that the Company received a notification letter from the New York Stock Exchange (the "NYSE") advising that because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period, it is not in compliance with Section 802.01C of the NYSE Listed Company Manual. The Company’s common stock will continue to be listed and traded on the NYSE, subjec |